$429 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGEN | Buy | SEAGEN INC | $46,447,000 | +39.9% | 262,502 | +13.9% | 10.83% | +32.4% |
| HUM | Buy | HUMANA INC | $37,535,000 | +10.7% | 80,191 | +3.0% | 8.75% | +4.8% |
| IQV | Buy | IQVIA HLDGS INC | $27,361,000 | +5.7% | 126,095 | +12.6% | 6.38% | -0.0% |
| ILMN | New | ILLUMINA INC | $21,959,000 | – | 119,108 | +100.0% | 5.12% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $21,787,000 | +1.7% | 149,380 | +13.8% | 5.08% | -3.8% |
| NTRA | Buy | NATERA INC | $20,236,000 | +11.2% | 570,994 | +27.6% | 4.72% | +5.2% |
| DXCM | Buy | DEXCOM INC | $17,671,000 | -11.2% | 237,100 | +509.5% | 4.12% | -16.0% |
| INSP | Buy | INSPIRE MED SYS INC | $17,199,000 | -12.1% | 94,153 | +23.5% | 4.01% | -16.9% |
| CANO | Buy | CANO HEALTH INC | $16,717,000 | -10.9% | 3,816,712 | +29.2% | 3.90% | -15.7% |
| OM | Buy | OUTSET MED INC | $15,142,000 | +1.4% | 1,018,960 | +209.7% | 3.53% | -4.1% |
| ISRG | New | INTUITIVE SURGICAL INC | $13,153,000 | – | 65,530 | +100.0% | 3.07% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $12,779,000 | +1.8% | 576,413 | +33.6% | 2.98% | -3.7% |
| TXG | New | 10X GENOMICS INC | $11,819,000 | – | 261,200 | +100.0% | 2.76% | – |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $9,828,000 | -30.2% | 1,214,860 | +19.7% | 2.29% | -34.0% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $1,825,000 | -8.6% | 261,423 | +97.9% | 0.42% | -13.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $394,000 | – | 23,500 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.